APA (7th ed.) Citation

Wang, C., Pan, Y., Liu, Y., Guo, B., Shi, J., Rong, G., . . . Han, W. (2023). Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessation. MedComm, 4(6), . https://doi.org/10.1002/mco2.428

Chicago Style (17th ed.) Citation

Wang, Chunmeng, et al. "Long‐term Complete Remission and Peripheral Biomarkers in Hodgkin Lymphoma Patients After Decitabine‐plus‐camrelizumab Epi‐immunotherapy and Treatment Cessation." MedComm 4, no. 6 (2023). https://doi.org/10.1002/mco2.428.

MLA (9th ed.) Citation

Wang, Chunmeng, et al. "Long‐term Complete Remission and Peripheral Biomarkers in Hodgkin Lymphoma Patients After Decitabine‐plus‐camrelizumab Epi‐immunotherapy and Treatment Cessation." MedComm, vol. 4, no. 6, 2023, https://doi.org/10.1002/mco2.428.